APIMEDS PHARMACEUTICALS US, INC. Paid-in-Kind Interest
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Paid-in-Kind Interest of $1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-14
- 2026-06-30: Paid-in-Kind Interest 6 month $1.21M.
- 2025-06-30: Paid-in-Kind Interest 6 month $21.25K.
| Period end | Paid-in-Kind Interest 6 month |
|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $21.25K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |